These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26519849)
21. Summary of BHIVA guidelines for HIV and hepatitis B or C co-infection. Brook MG J HIV Ther; 2003 Nov; 8(4):85-8. PubMed ID: 14671505 [TBL] [Abstract][Full Text] [Related]
22. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323 [TBL] [Abstract][Full Text] [Related]
23. [Prevention of noncommunicable diseases in a local therapist's practice: content, problems, solution ways, and prospects]. Boitsov SA; Vylegzhanin SV Ter Arkh; 2015; 87(1):4-9. PubMed ID: 25823263 [TBL] [Abstract][Full Text] [Related]
29. How should we manage incidentalomas? Sexton SM Am Fam Physician; 2014 Dec; 90(11):758-9. PubMed ID: 25611709 [No Abstract] [Full Text] [Related]
30. Good clinical practice standards: what they are and some tools to support them. Fromell GJ Hum Gene Ther; 2008 May; 19(5):431-40. PubMed ID: 18507512 [No Abstract] [Full Text] [Related]
31. [Management of children with HBV or HCV infection before and after liver and/or kidney transplantation]. Pawłowska J; Kaliciński P; Dzierzanowska-Fangrat K; Grenda R; Socha J; Woynarowski M; Cielecka-Kuszyk J Przegl Epidemiol; 2006; 60(4):685-92. PubMed ID: 17682749 [TBL] [Abstract][Full Text] [Related]
32. A framework to improve the quality of treatment for depression in primary care. Croghan TW; Schoenbaum M; Sherbourne CD; Koegel P Psychiatr Serv; 2006 May; 57(5):623-30. PubMed ID: 16675754 [TBL] [Abstract][Full Text] [Related]
33. [The program of early detection of HCV infection]. Borzecka B; Błudzin W Przegl Epidemiol; 2007; 61(4):733-8. PubMed ID: 18572505 [TBL] [Abstract][Full Text] [Related]
34. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]. Pár A Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671 [TBL] [Abstract][Full Text] [Related]
36. Present and future therapy for hepatitis C virus. Cornberg M; Deterding K; Manns MP Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355 [TBL] [Abstract][Full Text] [Related]
37. How to use virological tools for optimal management of chronic hepatitis C. Chevaliez S; Pawlotsky JM Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern(®) Guidelines. Feder RS; Olsen TW; Prum BE; Summers CG; Olson RJ; Williams RD; Musch DC Ophthalmology; 2016 Jan; 123(1):P209-36. PubMed ID: 26581558 [TBL] [Abstract][Full Text] [Related]
39. Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges. Zeisel MB; Lupberger J; Fofana I; Baumert TF J Hepatol; 2013 Feb; 58(2):375-84. PubMed ID: 23041307 [TBL] [Abstract][Full Text] [Related]
40. [Too few antibiotics: the second path to resistance]. Chuard C; Genné D Rev Med Suisse; 2015 Oct; 11(489):1827-8. PubMed ID: 26638511 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]